Stratmann, J. A., Michels, S., Hornetz, S., Christoph, D. C., Sackmann, S., Spengler, W., . . . Sebastian, M. (2018). Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology, 144(12), 2457-2463. https://doi.org/10.1007/s00432-018-2754-x
Chicago-referens (17:e uppl.)Stratmann, Jan A., et al. "Efficacy and Safety Analysis of the German Expanded Access Program of Osimertinib in Patients with Advanced, T790M-positive Non-small Cell Lung Cancer." Journal of Cancer Research and Clinical Oncology 144, no. 12 (2018): 2457-2463. https://doi.org/10.1007/s00432-018-2754-x.
MLA-referens (9:e uppl.)Stratmann, Jan A., et al. "Efficacy and Safety Analysis of the German Expanded Access Program of Osimertinib in Patients with Advanced, T790M-positive Non-small Cell Lung Cancer." Journal of Cancer Research and Clinical Oncology, vol. 144, no. 12, 2018, pp. 2457-2463, https://doi.org/10.1007/s00432-018-2754-x.
